Lymph Node Prep

Bruce Davis, MD - Clinical Pathology bdavis at beaumont.edu
Tue Mar 19 17:53:12 EST 1996


In >99.8% of cases, I see no reason for ficoll separation of LN samples
when using viability gating.  What are the 0.2%?  I don't know as I
haven't found one, but never say never.

Bruce H. Davis, M.D.
Wm. Beaumont Hosp.
Royal Oak, MI






More information about the Cytometry mailing list